本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Xeris製藥

5.11
-0.1600-3.04%
盤後5.110.00000.00%17:52 EDT
成交量:151.66萬
成交額:781.44萬
市值:8.18億
市盈率:-16.98
高:5.28
開:5.24
低:5.10
收:5.27
資料載入中...
2021/07/28

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/19

重要事件披露

8-K - Current report
2021/07/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/08

重要事件披露

8-K - Current report
2021/05/25

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/24

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/24

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/24

重要事件披露

8-K - Current report
2021/05/24

企業合併公告

425 - Prospectuses and communications, business combinations
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/13

重要事件披露

8-K - Current report
2021/05/06

重要事件披露

8-K - Current report
2021/03/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/03/11

重要事件披露

8-K - Current report
2021/03/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/09

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/09

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals